79306170 - M MENARINI STEMLINE

Information

• Trademark
• 79306170

• Source

• Serial Number

  79306170

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  January 14, 2021
  3 years ago

• Transaction Date

  March 21, 2023
  a year ago

• Status Date

  February 26, 2022
  2 years ago

• Location Date

  February 26, 2022
  2 years ago

• Status Code

  602

• Current Location

  TMO LAW OFFICE 123 - EXAMINING ATTORNEY ASSIGNED

  Employee Name

  HOPKINS, SARAH COLLEEN

• Law Office Assigned Location Code

  N50

• Owners

  • A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.R.L

Case File Statements

• DM0000: The mark consists of an upper-case letter "M" outlined in black, the interior of the letter is white, the two right triangles formed by the bottom of the "M" are of the color red, and the large isosceles triangle formed at the top of the letter "M" is black and is bisected from bottom to top by the name "MENARINI" in upper-case lettering in white; on the right side of the letter "M" is the name "MENARINI" in black in upper-case lettering and the name "STEMLINE" in black in lower-case letting, with the upper-case letter "S"; the color red is in the two right triangles formed by the bottom of the letter "M"; the color white is in the interior of the letter "M" in the name "MENARINI" that is inside the isosceles triangle formed at the top of the letter "M"; the color black is in the isosceles triangle formed at the top of the letter "M", in the names "MENARINI" and "STEMLINE".
• GS0051: Diagnostic reagents for medical use; pharmaceutical preparations and substances for the treatment of cancer
• PM0001: M MENARINI STEM LINE
• CC0000: The color(s) red, black and white is/are claimed as a feature of the mark.
• GS0421: Biomedical research services; pharmaceutical products development; design and testing of new products; testing of pharmaceuticals; medical and pharmacological research services; research and development in the pharmaceutical and biotechnology fields

Case File Event Statements

• 3/21/2023 - a year ago

  19 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINT

• 2/27/2023 - a year ago

  18 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 2/26/2023 - a year ago

  17 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 9/4/2022 - 2 years ago

  16 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX

• 8/17/2022 - 2 years ago

  15 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 8/17/2022 - 2 years ago

  14 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR

• 2/28/2022 - 2 years ago

  13 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Type: MAB2

• 2/26/2022 - 2 years ago

  12 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Type: MAB2

• 2/26/2022 - 2 years ago

  11 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2

• 8/29/2021 - 3 years ago

  10 - REFUSAL PROCESSED BY IB Type: RFNT

• 8/12/2021 - 3 years ago

  9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 8/12/2021 - 3 years ago

  8 - REFUSAL PROCESSED BY MPU Type: RFRR

• 8/1/2021 - 3 years ago

  7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 7/31/2021 - 3 years ago

  6 - NON-FINAL ACTION WRITTEN Type: CNRT

• 7/27/2021 - 3 years ago

  5 - ASSIGNED TO EXAMINER Type: DOCK

• 3/19/2021 - 3 years ago

  4 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 3/15/2021 - 3 years ago

  3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 3/12/2021 - 3 years ago

  2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED Type: LIMI

• 3/11/2021 - 3 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR